BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9338723)

  • 1. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of complicated renal colic in patients treated with indinavir: value of double J stents].
    Van Glabeke E; Conort P; Chartier-Kastler E; Desrez G; Boyer C; Richard F
    Prog Urol; 1999 Jun; 9(3):470-3. PubMed ID: 10434319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed.
    Reiter WJ; Schön-Pernerstorfer H; Dorfinger K; Hofbauer J; Marberger M
    J Urol; 1999 Apr; 161(4):1082-4. PubMed ID: 10081842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus.
    Kohan AD; Armenakas NA; Fracchia JA
    J Urol; 1999 Jun; 161(6):1765-8. PubMed ID: 10332431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urolithiasis associated with protease inhibitors.
    Sundaram CP; Saltzman B
    J Endourol; 1999 May; 13(4):309-12. PubMed ID: 10405912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitors and urolithiasis.
    Sutherland SE; Reigle MD; Seftel AD; Resnick MI
    J Urol; 1997 Jul; 158(1):31-3. PubMed ID: 9186316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging characteristics of indinavir calculi.
    Schwartz BF; Schenkman N; Armenakas NA; Stoller ML
    J Urol; 1999 Apr; 161(4):1085-7. PubMed ID: 10081843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyuria in patients treated with indinavir is associated with renal dysfunction.
    Sarcletti M; Petter A; Romani N; Lhotta K; König P; Maier H; Zangerle R
    Clin Nephrol; 2000 Oct; 54(4):261-70. PubMed ID: 11076101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The etiology of urolithiasis in HIV infected patients.
    Nadler RB; Rubenstein JN; Eggener SE; Loor MM; Smith ND
    J Urol; 2003 Feb; 169(2):475-7. PubMed ID: 12544290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
    Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
    Trainor LD; Steinberg JP; Austin GW; Solomon HM
    Arch Pathol Lab Med; 1998 Mar; 122(3):256-9. PubMed ID: 9823864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.
    Duval X; Journot V; Leport C; Chêne G; Dupon M; Cuzin L; May T; Morlat P; Waldner A; Salamon R; Raffi F;
    Clin Infect Dis; 2004 Jul; 39(2):248-55. PubMed ID: 15307035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal lithiasis due to indinavir].
    Fernández JM; Robles JE; Regojo JM; López J; Sánchez D; Arocena J; Rosell D; Zudaire JJ; Berián JM
    Rev Med Univ Navarra; 2002; 46(3):28-32. PubMed ID: 12685114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three patients with indinavir-related urolithiasis].
    Brandenburg JJ; Hoepelman IM; Stapper G; Lock MT
    Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1839-45. PubMed ID: 17874643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrolithiasis on indinavir.
    Prescrire Int; 1999 Feb; 8(39):22. PubMed ID: 10557573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.